Senhwa Biosciences, Inc. (TPEx: 6492), a new drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and infectious diseases, today announced that the completion ...

SSE is poised to profit from Britain's goal to decarbonise its electricity sector by 2030 with rapid expansion in renewable ...

The effect of U.S. tariffs on Italian companies will be massive, the head of national industry lobby Confindustria said on ...

US stock futures rose as Wall Street braced for President Trump's announcement of new tariffs that stand to remake the global trade order.